72 - Controversies and Challenges in Pediatric Transplant Infectious Diseases

Thursday, October 20, 2022

1:45 PM – 3:00 PM US ET

Location: Ballroom ABC (3rd Floor)

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Hayley Gans, MD

Clinical Professor
Stanford University
Palo Alto, CA, United States

Disclosure(s): No financial relationships to disclose

Slides
Daniel Dulek, MD

Assistant Professor of Pediatrics
Vanderbilt University Medical Center; Monroe Carell Jr. Children's Hospital

Disclosure(s): Eurofins-Viracor: Grant/Research Support (Ongoing); Horizon Therapeutics: Advisor/Consultant (Terminated)

Faculty(s)

Octavio Ramilo, MD

Professor and Division Chief
Infectious Diseases
Nationwide Children's Hospital
Columbus, Ohio, United States

Disclosure(s): Adagio: Advisor/Consultant (Ongoing); Bill & Melinda Gates Foundation: Grant/Research Support (Ongoing); Janssen: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Lilly: Advisor/Consultant (Terminated); Merck: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); NIH: Grant/Research Support (Ongoing); Pfizer: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Sanofi: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

Slides
Brian Fisher, DO, MSCE

Associate Professor of Pediatrics and Epidemiology
University of Pennsylvania, PA, United States

Disclosure(s): AlloVir: Grant/Research Support (Ongoing); Astellas Pharma Inc.: I receive reimbursement for serving on a Data Safety Monitoring Board (Ongoing); Merck and Company, Inc.: Grant/Research Support (Ongoing)

Slides
Marian Michaels, MD, MPH

Professor
Pediatrics
University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh
Pittsburgh, PA, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Hayley Gans, MD: No financial relationships to disclose

Daniel Dulek, MD: Eurofins-Viracor: Grant/Research Support (Ongoing); Horizon Therapeutics: Advisor/Consultant (Terminated)

Octavio Ramilo, MD: Adagio: Advisor/Consultant (Ongoing); Bill & Melinda Gates Foundation: Grant/Research Support (Ongoing); Janssen: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Lilly: Advisor/Consultant (Terminated); Merck: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); NIH: Grant/Research Support (Ongoing); Pfizer: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Sanofi: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

Brian Fisher, DO, MSCE: AlloVir: Grant/Research Support (Ongoing); Astellas Pharma Inc.: I receive reimbursement for serving on a Data Safety Monitoring Board (Ongoing); Merck and Company, Inc.: Grant/Research Support (Ongoing)

Marian G. Michaels, MD, MPH: No financial relationships to disclose

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

apply the use of diagnostic omics to clinical management of immunocompromised children;
appreciate the changes in microorganisms causing infections in children with fever and neutropenia and implications for prevention and treatment

Presentations:

1:45 PM – 2:10 PM US ET

Diagnostic “omics” Potential Application in Transplant Infectious Diseases
Speaker: Octavio Ramilo, MD – Nationwide Children's Hospital
2:10 PM – 2:35 PM US ET

Looking Back and Forward: Fever and Neutropenia
Speaker: Brian Fisher, DO, MSCE – University of Pennsylvania
2:35 PM – 3:00 PM US ET

Should I Accept This Organ: Decision-Making Process of Organ Acceptance: A Case-Based Exploration
Speaker: Marian G. Michaels, MD, MPH – University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh